Related Experiment Video

Updated: Mar 29, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K

MicroRNAs: Clinical Relevance in Colorectal Cancer

Joe Thomas1, Masahisa Ohtsuka2, Martin Pichler3,4

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. thomjoea@iupui.edu.

International Journal of Molecular Sciences
|November 26, 2015
PubMed

Insights

MicroRNAs show significant promise as biomarkers and therapeutic targets for colorectal cancer. These small regulatory RNAs can be utilized for improved diagnosis, prognosis, and novel treatment strategies for this common malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer is a leading cause of cancer mortality globally.
  • MicroRNAs (miRNAs), small non-coding RNAs, regulate gene expression and are implicated in cancer development.
  • Dysregulated miRNA expression is linked to various cancer types and stages.

Purpose of the Study:

  • To explore the role of microRNAs in colorectal cancer.
  • To evaluate the potential of microRNAs as diagnostic and prognostic biomarkers.
  • To assess microRNA-based therapeutics for colorectal cancer treatment.

Main Methods:

  • Review of current literature on microRNA function in colorectal cancer.
  • Analysis of miRNA expression profiles in colorectal cancer patients.
  • Examination of preclinical data for microRNA mimics and antagonists as therapeutics.

Main Results:

  • MicroRNAs are significantly associated with colorectal cancer development and progression.
  • Unique miRNA expression profiles correlate with specific colorectal cancer subtypes and malignancy.
  • Preclinical studies demonstrate the therapeutic potential of microRNA-based interventions.

Conclusions:

  • MicroRNAs hold considerable promise for the diagnosis and prognosis of colorectal cancer.
  • MicroRNA therapeutics offer a novel therapeutic strategy for colorectal cancer.
  • Further clinical development of microRNAs as biomarkers and therapeutic targets is warranted.
Keywords:
colorectal cancerdiagnosismiRNApathophysiologyprognosistreatment

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K